<DOC>
	<DOCNO>NCT01083199</DOCNO>
	<brief_summary>1 . To evaluate Device performance provide mucosa mucosa apposition facilitate sustainable vesico-urethral anastomosis radical prostatectomy procedure . 2 . To assess clinical outcome Device facilitate vesico-urethral anastomosis follow radical prostatectomy .</brief_summary>
	<brief_title>Global Performance Evaluation AMS CONTINUUM™ Device</brief_title>
	<detailed_description>Radical prostatectomy ( RP ) utilize surgical treatment option localize prostate cancer due multi-focal nature disease . RP suitable otherwise healthy men whose cancer limit small area . The RP procedure involve remove prostate gland , seminal vesicle nearby lymph node . One technically challenge critical aspect surgical approach reconstruction interrupt urinary tract hand sew vesico-urethral anastomosis . This bladder neck sewn urethra prostate remove . CONTINUUM™ ( study Device ) use part RP procedure facilitate approximation bladder neck urethral stump . The Device bring together hold tissue place adequate natural heal vesico-urethral anastomosis occur thereby minimizing extravasation . The Device also provide conduit drainage urine bladder urethra tissue healing . The concept CONTINUUM™ device feasibility operation successfully test animal human study . Pilot clinical study United States ( G060095 ) find majority subject receive discharged Device demonstrate water-tight vesico-urethral anastomosis first Device removal visit . Additionally , unanticipated adverse device effect ( UADEs ) report . The focus propose study verify performance Device global research center .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>All male ≥ 40 year old indicate radical prostatectomy eligible participate study If contraindicate surgery Inability understand study history noncompliance medical advice Unwilling unable sign Informed Consent Form ( ICF ) A history : 1 . Recurrent urinary tract infection ( UTI ) 2 . Recurrent stricture disease Neurological disease history bladder dysfunction ( e.g. , Parkinson 's disease ) Uncontrolled insulindependent diabetes Chemotherapy within past 6 month Nontopical steroid use within past 6 month Allergy nitinol , nickel , titanium silicone</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Radical Prostatectomy</keyword>
	<keyword>Vesico-Urethral Anastomosis</keyword>
</DOC>